Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
Article ID | PMID | Source | Title | Publish Year | |
---|---|---|---|---|---|
A16606 | 28286210 | Gastroenterology | Using a 3% Proton Density Fat Fraction as a Cut-Off Value Increases Sensitivity of Detection of Hepatic Steatosis, Based on Results From Histopathology Analysis. | 2017 | Details |
A16607 | 28286193 | Clin Gastroenterol Hepatol | In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis. | 2017 | Details |
A16608 | 28285648 | Metabolism | Branched-chain amino acids alleviate hepatic steatosis and liver injury in choline-deficient high-fat diet induced NASH mice. | 2017 | Details |
A16609 | 28285394 | Inflamm Res | HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. | 2017 | Details |
A16610 | 28284571 | Med Eng Phys | Dynamic mechanical analysis to assess viscoelasticity of liver tissue in a rat model of nonalcoholic fatty liver disease. | 2017 | Details |
A16611 | 28284005 | Curr HIV/AIDS Rep | Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV. | 2017 | Details |
A16612 | 28283691 | Internist (Berl) | [Modulation of the intestinal microbiota by nutritional interventions]. | 2017 | Details |
A16613 | 28283346 | Eur J Intern Med | Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes? | 2017 | Details |
A16614 | 28282876 | Int J Mol Sci | Hepatic Transcriptome Profiles of Mice with Diet-Induced Nonalcoholic Steatohepatitis Treated with Astaxanthin and Vitamin E. | 2017 | Details |
A16615 | 28282659 | Horm Metab Res | Low Serum Sex Hormone-Binding Globulin Associated with Insulin Resistance in Men with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A16616 | 28281517 | Ter Arkh | [Diabetes mellitus and nonalcoholic fatty liver disease: The verges of contingency]. | 2017 | Details |
A16617 | 28281516 | Ter Arkh | [Features of a necrotic and inflammatory process in different forms of nonalcoholic fatty liver disease]. | 2017 | Details |
A16618 | 28281515 | Ter Arkh | [Clinical and metabolic features of nonalcoholic fatty liver disease in men and women]. | 2017 | Details |
A16619 | 28281514 | Ter Arkh | [Ultrasound elastography of the liver for assessing the risk of complications of its cirrhosis of different etiologies]. | 2017 | Details |
A16620 | 28281237 | Obes Surg | Adipokine Levels Versus Hepatic Histopathology in Bariatric Surgery Patients. | 2017 | Details |
A16621 | 28279536 | Med Clin (Barc) | Clinical characteristics of hepatocellular carcinoma in Spain. Comparison with the 2008-2009 period and analysis of the causes of diagnosis out of screening programs. Analysis of 686 cases in 73 centers. | 2017 | Details |
A16622 | 28278289 | PLoS One | Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. | 2017 | Details |
A16623 | 28278002 | Radiology | Quantifying Abdominal Adipose Tissue and Thigh Muscle Volume and Hepatic Proton Density Fat Fraction: Repeatability and Accuracy of an MR Imaging-based, Semiautomated Analysis Method. | 2017 | Details |
A16624 | 28277977 | Epigenetics | Human liver epigenetic alterations in non-alcoholic steatohepatitis are related to insulin action. | 2017 | Details |
A16625 | 28277807 | Expert Rev Clin Pharmacol | Magnetic resonance imaging and transient elastography in the management of Nonalcoholic Fatty Liver Disease (NAFLD). | 2017 | Details |
A16627 | 28276821 | Expert Rev Gastroenterol Hepatol | Current and future treatment options in non-alcoholic steatohepatitis (NASH). | 2017 | Details |
A16628 | 28276774 | Expert Rev Clin Pharmacol | Pharmacological management of nonalcoholic fatty liver disease in type 2 diabetes. | 2017 | Details |
A16629 | 28275212 | Int J Mol Sci | Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis. | 2017 | Details |
A16631 | 28274829 | Dig Liver Dis | Vitamin D and histologic severity of nonalcoholic fatty liver disease: A systematic review and meta-analysis. | 2017 | Details |
A16632 | 28274625 | Eur J Pharmacol | APD668, a G protein-coupled receptor 119 agonist improves fat tolerance and attenuates fatty liver in high-trans fat diet induced steatohepatitis model in C57BL/6 mice. | 2017 | Details |
A16633 | 28273805 | Nutrients | Fructose and NAFLD: The Multifaceted Aspects of  Fructose Metabolism. | 2017 | Details |
A16634 | 28273479 | Cell Metab | Systems Biology of Metabolism: A Driver for Developing Personalized and Precision Medicine. | 2017 | Details |
A16635 | 28273155 | PLoS One | Tumor stroma with senescence-associated secretory phenotype in steatohepatitic hepatocellular carcinoma. | 2017 | Details |
A16636 | 28271632 | IUBMB Life | The role of insufficient copper in lipid synthesis and fatty-liver disease. | 2017 | Details |
A16637 | 28271033 | Mol Metab | Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis. | 2017 | Details |
A16638 | 28271032 | Mol Metab | Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice. | 2017 | Details |
A16639 | 28270882 | J Clin Med Res | Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment. | 2017 | Details |
A16641 | 28270609 | Proc Natl Acad Sci U S A | Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis. | 2017 | Details |
A16642 | 28270444 | Am J Physiol Endocrinol Metab | α-Linolenic acid supplementation and exercise training reveal independent and additive responses on hepatic lipid accumulation in obese rats. | 2017 | Details |
A16643 | 28269075 | Annu Int Conf IEEE Eng Med Biol Soc | Early diagnosis of NAFLD-NASH transition using mid infrared spectroscopy. | 2016 | Details |
A16644 | 28268262 | Clin Mol Hepatol | Genetic predisposition in nonalcoholic fatty liver disease. | 2017 | Details |
A16645 | 28267621 | J Hepatol | Targeting hepatic macrophages to treat liver diseases. | 2017 | Details |
A16646 | 28267360 | AJR Am J Roentgenol | A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A16647 | 28266792 | J Clin Hypertens (Greenwich) | The science of salt: A regularly updated systematic review of salt and health outcomes (December 2015-March 2016). | 2017 | Details |
A16648 | 28266626 | Sci Rep | Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity. | 2017 | Details |
A16649 | 28266614 | Sci Rep | A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. | 2017 | Details |
A16650 | 28265826 | Dig Dis Sci | Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients. | 2017 | Details |
A16651 | 28264657 | BMC Gastroenterol | "Non alcoholic fatty liver disease and eNOS dysfunction in humans". | 2017 | Details |
A16652 | 28264426 | Nutrients | The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α. | 2017 | Details |
A16653 | 28263100 | Autoimmunity | Decreased serum DNase1-activity in patients with autoimmune liver diseases. | 2017 | Details |
A16654 | 28262979 | J Cell Biochem | Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1-Dependent Mechanism During Hepatocyte Lipotoxicity. | 2017 | Details |
A16655 | 28262209 | Am J Med Sci | Serum Lipid Abnormalities and Nonalcoholic Fatty Liver Disease in Adult Males. | 2017 | Details |
A16656 | 28262196 | Arch Med Res | Serum Chemerin in Obese Children and Adolescents Before and After L-Carnitine Therapy: Relation to Nonalcoholic Fatty Liver Disease and Other Features of Metabolic Syndrome. | 2016 | Details |
A16657 | 28260907 | Ther Clin Risk Manag | Effect of orlistat on periostin, adiponectin, inflammatory markers and ultrasound grades of fatty liver in obese NAFLD patients. | 2017 | Details |
A16658 | 28260764 | Mymensingh Med J | Sonographically Detected Non Alcoholic Fatty Liver Disease in Apparently Healthy Adults and Associated Factors. | 2017 | Details |
A16659 | 28260070 | Int J Mol Med | A long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, as a preventive drug for the development of hepatic steatosis in high-fructose diet-fed ob/ob mice. | 2017 | Details |
A16660 | 28258704 | Hepatol Res | Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. | 2017 | Details |
A16661 | 28257781 | Food Chem Toxicol | Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress. | 2017 | Details |
A16662 | 28257594 | Hepatol Res | Ezetimibe for the treatment of non-alcoholic fatty liver disease: A meta-analysis. | 2017 | Details |
A16663 | 28257515 | PLoS One | New evidence for the therapeutic potential of curcumin to treat nonalcoholic fatty liver disease in humans. | 2017 | Details |
A16664 | 28257306 | Curr Opin Gastroenterol | Intestinal microbiota and nonalcoholic steatohepatitis. | 2017 | Details |
A16665 | 28256569 | Mod Pathol | Aggressive non-alcoholic steatohepatitis following rapid weight loss and/or malnutrition. | 2017 | Details |
A16666 | 28256088 | Diabetes Obes Metab | Prevalence of elevated liver enzymes in adults with type 1 diabetes: A multicentre analysis of the German/Austrian DPV database. | 2017 | Details |
A16667 | 28255371 | J Med Life | Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods. | 2017 | Details |
A16668 | 28254760 | Mol Syst Biol | Personal model-assisted identification of NAD+ and glutathione metabolism as intervention target in NAFLD. | 2017 | Details |
A16669 | 28254666 | Biomed Pharmacother | Kukoamine A attenuates insulin resistance and fatty liver through downregulation of Srebp-1c. | 2017 | Details |
A16670 | 28254449 | J Diabetes Complications | Nonalcoholic fatty liver disease is associated with an increased prevalence of distal symmetric polyneuropathy in adult patients with type 1 diabetes. | 2017 | Details |
A16672 | 28253211 | Eur J Gastroenterol Hepatol | Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation. | 2017 | Details |
A16673 | 28253210 | Eur J Gastroenterol Hepatol | The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study. | 2017 | Details |
A16674 | 28252464 | Eur J Gastroenterol Hepatol | Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
A16675 | 28252430 | Georgian Med News | [EATING DISORDERS AND VISCERAL ADIPOSE TISSUE - TWO INTERCONNECTED INFORMATIVE MARKERS OF PROGNOSIS OF DISORDERS OF NUTRITIONAL STATUS AND RISK OF DEVELOPMENT OF COMORBIDITY CHRONIC NON-COMMUNICABLE DISEASES]. | 2017 | Details |
A16676 | 28251449 | Inflammation | A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses. | 2017 | Details |
A16677 | 28250783 | J Res Med Sci | Do symbiotic and Vitamin E supplementation have favorite effects in nonalcoholic fatty liver disease? A randomized, double-blind, placebo-controlled trial. | 2016 | Details |
A16678 | 28250338 | Biosci Trends | Key role of liver sinusoidal endothelial cells in liver fibrosis. | 2017 | Details |
A16679 | 28250290 | Intern Med | The Relationship between the Growth Hormone/Insulin-like Growth Factor System and the Histological Features of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
A16680 | 28249275 | Dig Dis | Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease. | 2017 | Details |
A16681 | 28249273 | Dig Dis | Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation. | 2017 | Details |
A16682 | 28249257 | Dig Dis | Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
A16683 | 28249038 | PLoS One | Microvesicles released from fat-laden cells promote activation of hepatocellular NLRP3 inflammasome: A pro-inflammatory link between lipotoxicity and non-alcoholic steatohepatitis. | 2017 | Details |
A16684 | 28245087 | Hepatol Res | Hepatic nucleotide binding oligomerization domain-like receptors pyrin domain-containing 3 inflammasomes are associated with the histologic severity of non-alcoholic fatty liver disease. | 2017 | Details |
A16685 | 28244714 | Asia Pac J Clin Nutr | Serum uric acid levels in non-alcoholic steatosis patients: a meta-analysis. | 2017 | Details |
A16686 | 28244519 | Food Funct | A diet containing a high- versus low-daidzein level does not protect against liver steatosis in the obese Zucker rat model. | 2017 | Details |
A16687 | 28244120 | Hepatology | The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice. | 2017 | Details |
A16688 | 28243042 | Ann Gastroenterol | Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease. | 2016 | Details |
A16689 | 28242789 | J Lipid Res | TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. | 2017 | Details |
A16690 | 28241825 | BMC Med | Non-alcoholic fatty liver disease. | 2017 | Details |
A16691 | 28241817 | BMC Endocr Disord | Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease. | 2017 | Details |
A16692 | 28241279 | JAMA Intern Med | Thiazolidinediones and Advanced Liver Fibrosis in Nonalcoholic Steatohepatitis: A Meta-analysis. | 2017 | Details |
A16694 | 28241076 | PLoS One | Characterisation of liver fat in the UK Biobank cohort. | 2017 | Details |
A16695 | 28239403 | Nutr Metab (Lond) | Lipid overload during gestation and lactation can independently alter lipid homeostasis in offspring and promote metabolic impairment after new challenge to high-fat diet. | 2017 | Details |
A16696 | 28239368 | Front Endocrinol (Lausanne) | Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights. | 2017 | Details |
A16697 | 30263537 | Food Sci Biotechnol | Inhibitory effect of esculetin on free-fatty-acid-induced lipid accumulation in human HepG2 cells through activation of AMP-activated protein kinase. | 2017 | Details |
A16699 | 28235711 | Atherosclerosis | Race/ethnic and sex disparities in the non-alcoholic fatty liver disease-abdominal aortic calcification association: The Multi-Ethnic Study of Atherosclerosis. | 2016 | Details |
A16700 | 28235613 | J Hepatol | Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD. | 2017 | Details |
A16701 | 28235154 | Liver Int | Metabolic syndrome and severity of fibrosis in nonalcoholic fatty liver disease: An age-dependent risk profiling study. | 2017 | Details |
A16702 | 28234943 | PLoS One | High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men. | 2017 | Details |
A16703 | 28233740 | Ann Hepatol | Hepatitis B and NAFLD: Lives Crossed. | 2017 | Details |
A16704 | 28233737 | Ann Hepatol | Perspectives on NASH Histology: Cellular Ballooning. | 2017 | Details |
A16705 | 28232481 | FASEB J | Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance. | 2017 | Details |
A16706 | 28232454 | Am J Physiol Gastrointest Liver Physiol | A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition. | 2017 | Details |
A16707 | 28231800 | Lipids Health Dis | Dietary intervention, but not losartan, completely reverses non-alcoholic steatohepatitis in obese and insulin resistant mice. | 2017 | Details |
A16708 | 28231412 | Liver Int | Impact of family history of metabolic traits on severity of non-alcoholic steatohepatitis related cirrhosis: A cross-sectional study. | 2017 | Details |
A16709 | 28231052 | Acta Pharm | Review. The role of peroxisome proliferator-activated receptor in the treatment of non-alcoholic fatty liver disease. | 2017 | Details |
A16710 | 28230607 | J Pediatr Gastroenterol Nutr | Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents. | 2017 | Details |
A16711 | 28230324 | Diabetes Obes Metab | Effects of short-term energy restriction on liver lipid content and inflammatory status in severely obese adults: Results of a randomized controlled trial using 2 dietary approaches. | 2017 | Details |